Our results indicate the potential of piplartine to treat malaria, including its inhibitory effects in the production of reactive oxygen species and in the cellular pathways related to the production of cytokines, JNK and NF-κB (Xiao et al. This evidence concerns the gene MAPK8 and malaria.